Cargando…

Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results

Aim: This study aimed to present the short- and long-term results of Demirtas two-step treatment model in patients with obstructed-hydronephrotic kidneys functioning below 10%, and before deciding on nephrectomy, to evaluate whether this method can contribute to the accurate assessment. Material and...

Descripción completa

Detalles Bibliográficos
Autores principales: Demirtaş, Abdullah, Golbasi, Abdullah, Guleser, Ahmet S, Sönmez, Gökhan, Demirtaş, Türev, GÜR, Ahmet, Tombul, Şevket T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298605/
https://www.ncbi.nlm.nih.gov/pubmed/35875311
http://dx.doi.org/10.7759/cureus.26128
_version_ 1784750745520701440
author Demirtaş, Abdullah
Golbasi, Abdullah
Guleser, Ahmet S
Sönmez, Gökhan
Demirtaş, Türev
GÜR, Ahmet
Tombul, Şevket T
author_facet Demirtaş, Abdullah
Golbasi, Abdullah
Guleser, Ahmet S
Sönmez, Gökhan
Demirtaş, Türev
GÜR, Ahmet
Tombul, Şevket T
author_sort Demirtaş, Abdullah
collection PubMed
description Aim: This study aimed to present the short- and long-term results of Demirtas two-step treatment model in patients with obstructed-hydronephrotic kidneys functioning below 10%, and before deciding on nephrectomy, to evaluate whether this method can contribute to the accurate assessment. Material and methods: This prospective study included patients with unilateral renal obstruction and renal parenchymal loss assessed by computed tomography and whose renal function was found to be below 10% in Tc-99m-dimercaptosuccinic acid. In the first step, percutaneous nephrostomy (PCN) was performed. Two weeks later, the second step was performed, in which patients were offered nephrectomy (if renal function was <10%) or etiology-based treatment (if renal function was ≥10%). Results: Thirty-eight patients were included in the study, comprising 20 (52.6%) men and 18 (47.4%) women with a mean age of 51.3±16.8 years. Mean baseline renal function was 6.0%, which increased to 10.8% two weeks after PCN (p=0.001). Renal function increased to above 10% in 20 (52.6%) out of 38 patients. Of these, 17 patients underwent etiology-based treatment and baseline, two-week, and 12-month renal function levels were 7.0%, 17.5%, and 18.8%, respectively (p<0.001). Conclusion: Demirtas two-step treatment model introduced in the present study can be recommended as a standard treatment modality in unilaterally obstructed kidneys functioning below 10% ability.
format Online
Article
Text
id pubmed-9298605
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-92986052022-07-22 Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results Demirtaş, Abdullah Golbasi, Abdullah Guleser, Ahmet S Sönmez, Gökhan Demirtaş, Türev GÜR, Ahmet Tombul, Şevket T Cureus Urology Aim: This study aimed to present the short- and long-term results of Demirtas two-step treatment model in patients with obstructed-hydronephrotic kidneys functioning below 10%, and before deciding on nephrectomy, to evaluate whether this method can contribute to the accurate assessment. Material and methods: This prospective study included patients with unilateral renal obstruction and renal parenchymal loss assessed by computed tomography and whose renal function was found to be below 10% in Tc-99m-dimercaptosuccinic acid. In the first step, percutaneous nephrostomy (PCN) was performed. Two weeks later, the second step was performed, in which patients were offered nephrectomy (if renal function was <10%) or etiology-based treatment (if renal function was ≥10%). Results: Thirty-eight patients were included in the study, comprising 20 (52.6%) men and 18 (47.4%) women with a mean age of 51.3±16.8 years. Mean baseline renal function was 6.0%, which increased to 10.8% two weeks after PCN (p=0.001). Renal function increased to above 10% in 20 (52.6%) out of 38 patients. Of these, 17 patients underwent etiology-based treatment and baseline, two-week, and 12-month renal function levels were 7.0%, 17.5%, and 18.8%, respectively (p<0.001). Conclusion: Demirtas two-step treatment model introduced in the present study can be recommended as a standard treatment modality in unilaterally obstructed kidneys functioning below 10% ability. Cureus 2022-06-20 /pmc/articles/PMC9298605/ /pubmed/35875311 http://dx.doi.org/10.7759/cureus.26128 Text en Copyright © 2022, Demirtaş et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Urology
Demirtaş, Abdullah
Golbasi, Abdullah
Guleser, Ahmet S
Sönmez, Gökhan
Demirtaş, Türev
GÜR, Ahmet
Tombul, Şevket T
Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results
title Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results
title_full Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results
title_fullStr Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results
title_full_unstemmed Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results
title_short Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results
title_sort demirtas two-step treatment model in hypofunctional-obstructed kidneys: an extended series and long-term prospective results
topic Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298605/
https://www.ncbi.nlm.nih.gov/pubmed/35875311
http://dx.doi.org/10.7759/cureus.26128
work_keys_str_mv AT demirtasabdullah demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults
AT golbasiabdullah demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults
AT guleserahmets demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults
AT sonmezgokhan demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults
AT demirtasturev demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults
AT gurahmet demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults
AT tombulsevkett demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults